MedPath

PORTAS 2, Comparing Venae Sectio Versus Punction of Vena Subclavia for Insertion of a Totally Implantable Access Port

Not Applicable
Completed
Conditions
Cancer
Registration Number
NCT00600444
Lead Sponsor
Heidelberg University
Brief Summary

The purpose of this trial is to investigate if the success rate of punction the vena subclavia (99% in retrospective studies) will be 15% higher than the success rate of venae sectio (80% in retro and prospective studies) for implantation of a totally implantable access ports.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Age equal or greater than 18 years
  • Patients scheduled for primary elective implantation of TIAP
Exclusion Criteria
  • Participation in another clinical trial which could interfere with the primary endpoint of this study
  • Lack of compliance
  • Impaired mental state or language problem
  • Patients with known allergy to contrast agent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Primary success rate of the randomized interventionAssessed on the day of surgery (day 0)
Secondary Outcome Measures
NameTimeMethod
Peri-/postoperative complication rate for the randomized interventionAssessed after 90 day post operation

Trial Locations

Locations (1)

University of Heidelberg

🇩🇪

Heidelberg, Baden Würtemberg, Germany

University of Heidelberg
🇩🇪Heidelberg, Baden Würtemberg, Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.